What's in Astex Pharmaceuticals, Inc.'s pipeline?

Astex Pharmaceuticals, Inc. has 9 drugs in our index: 1 marketed, 0 filed, 2 in Phase 3, 2 in Phase 2, 4 in Phase 1.

Which companies overlap with Astex Pharmaceuticals, Inc.'s portfolio?

Top competitors by shared drug class: Pfizer, Akeso, Artcline GmbH, Centre Leon Berard, Chengdu Zenitar Biomedical Technology Co., Ltd.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/astex-pharmaceuticals-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Astex Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief

Astex Pharmaceuticals, Inc. pipeline: 1 marketed, 0 filed, 2 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 2 Phase 3 2 Phase 2 4 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Treatment Choice	Treatment Choice	marketed	Small molecule inhibitor	DNA repair enzyme	Oncology
Decitabine/Cedazuridine	Decitabine/Cedazuridine	phase 3	DNA methyltransferase inhibitor; hypomethylating agent	DNA methyltransferase (DNMT)	Oncology
Treatment Choice (TC)	Treatment Choice (TC)	phase 3	SIRPα inhibitor	CD47	Oncology

Therapeutic area mix

Oncology · 5

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Pfizer · 2 shared drug classes
Akeso · 1 shared drug class
Artcline GmbH · 1 shared drug class
Centre Leon Berard · 1 shared drug class
Chengdu Zenitar Biomedical Technology Co., Ltd · 1 shared drug class
Jiangsu HengRui Medicine Co., Ltd. · 1 shared drug class
Jiangsu ShengDiYa Medicine Co., Ltd. · 1 shared drug class
Nanjing Leads Biolabs Co.,Ltd · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Astex Pharmaceuticals, Inc.:

Cite this brief

Drug Landscape (2026). Astex Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/astex-pharmaceuticals-inc. Accessed 2026-05-16.